CRC screening by gender were mixed, but qualitative studies highlighted fear of experimentation and intrusiveness of screening methods as unique themes among African American men. Limitations include heterogeneity in mistrust and CRC measures, and possible publication bias. Future studies should address methodological challenges found in this review, such as limited use of validated and reliable mistrust measures, examination of CRC screening outcomes beyond beliefs and intent, and a more thorough analysis of gender roles in the cancer screening process.
Background
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States, and approximately 51,000 Americans die each year from this disease [1] . National guidelines from the U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society recommend screening for CRC using fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy among average risk adults [2] . Adherence to these screening recommendations, which are in place for asymptomatic individuals between 50 and 75 years old, has been associated with a net reduction in CRC incidence and improved survival rate among the general population. However, these commonly adopted recommendations do not offer targeted strategies for individuals at highest risk for developing colorectal cancer. African Americans have a higher incidence of and mortality from CRC, and also experience greater morbidity and lower quality of health care compared with non-Hispanic Whites [3, 4] . Given these disparities in outcomes, access and timely use of approved screening procedures is of critical importance among African Americans.
In fact, despite the life-saving potential and enhanced net benefits of screening, approximately 27.7% of Americans age 50-75 have not received timely screening for colorectal cancer [5] and African Americans have a lower uptake of CRC screening than non-Hispanic whites [6] [7] [8] . Racial disparities in CRC screening adherence are further exacerbated by gender, with African American men exhibiting a lower likelihood of being screened than African American women [9, 10] . Economic and interpersonal factors associated with reduced uptake of CRC screening among African Americans have been well documented in previous empirical studies and include poor patient/provider communication and socioeconomic challenges, such as insurance status, socioeconomic status, and cost, in obtaining quality CRC screening [11, 12] . However, emerging literature also identifies psychosocial influences, such as cultural norms, differential perceptions of risk, and negatives attitudes towards healthcare, as primary barriers to receiving timely colorectal cancer screening in the African American population [6, 13] . Among these factors, lack of trust in the healthcare system remains a paramount psychosocial influence for reduced uptake of cancer screening in the United States [14] . Mistrust of the healthcare system and its providers, also known as medical mistrust, is associated with lower health services utilization among African American patients [15, 16] and is a widely cited attitudinal barrier to CRC screening and treatment seeking [17] .
Many studies consider mistrust from an interpersonal perspective, assessing this construct specifically within the patient-provider relationship. However, medical mistrust also reflects a belief system that, because of historical and lived experiences, patients are guarded about organizational-level policies and healthcare system procedures [18] . Investigations measuring medical mistrust at the physician and organizational levels and their associations with cancer screening appear to yield conflicting results [19, 20] . Organizational-level mistrust has also only recently received focused empiric attention, and its impact on cancer screening has not been thoroughly explored. As a result, less is known about its contribution to poor CRC screening uptake among African Americans. In addition, as African American men report higher levels of medical mistrust than African American women [21, 22] it is important to synthesize what is known about gender differences in associations between medical mistrust and CRC screening.
The primary goal of this study is to systematically review studies investigating associations between medical mistrust, at both the physician and organizational level, and uptake of CRC screening among African Americans. To examine whether medical mistrust has a significant influence on colorectal cancer screening patterns among African Americans, we reviewed empirical literature assessing the role of mistrust in providers or the healthcare system to determine whether this indicator has an impact on CRC screening utilization, beliefs, and attitudes among African Americans in the United States. Additionally, we examined gender differences in medical mistrust as well as preferred methods of CRC screening (e.g. FOBT, colonoscopy, etc.) within this population. We specifically address the following key questions:
KQ1: How does mistrust of health care providers and/or organizations impact CRC screening behavior among African Americans?
KQ2: How does medical mistrust differentially impact CRC screening patterns among African American men and women?
KQ3: How does medical mistrust impact the types of CRC screening African Americans receive (e.g., FOBT, colonoscopy, or flexible sigmoidoscopy)?
KQ4: Is there a differential impact on CRC screening behavior depending on whether mistrust is measured at the individual provider or organization level?
Methods
An a priori study protocol was submitted to PROSPERO to guide implementation of the review. Original, empirical studies investigating medical mistrust and colorectal cancer screening outcomes published from January 2000 to November 2016 were examined for this study. Studies with a sample of African American adult participants and a measure or theme related to physician or health organization mistrust were included in our study. The primary outcome of interest was CRC screening outcomes (i.e., screening-receipt: yes/no, beliefs, knowledge, and attitudes towards screening). We searched MEDLINE (Pubmed), CINAHL, Web of Science, PsycINFO, Google Scholar, Cochrane Database, and EMBASE. Search strategies for each database were developed in coordination with a research librarian specializing in systematic reviews. We limited searches to articles published in English and used search terms and Medical Subject Headings (MeSH) terms related to colorectal cancer, African Americans, and mistrust (See online material). We also included search terms for various types of CRC screening methods (i.e. FOBT, colonoscopy, etc.). Additional studies were also included by examining reference lists of included studies.
Two investigators independently screened abstracts and titles for inclusion to the full text review. Full text articles were screened by the same two investigators. Discrepancies between investigators were resolved by consensus at team meetings. We included studies using the following criteria: Studies must (1) Only include human subjects and be published in English; (2) Be empirical or analytical studies; (3) Be conducted in the United States; (4) Be published between January 2000 (two years before the USPSTF's recommendations for CRC screening starting at age 50 or older were published) and November 2016; (5) Include African Americans; (6) Discuss changes in CRC screening outcomes. Alternatively, studies were excluded if they: (1) Were commentaries or non-empirical studies; (2) Focus exclusively on foreign born Blacks or other racial/ethnic groups; (3) Focus solely on policy reviews and implementation.
Subgroup analyses were pre-specified in the Key Questions. The impact of medical mistrust on colorectal cancer screening rates was stratified by gender. This analysis was conducted to clarify gender differences in associations between medical mistrust and CRC screening outcomes. Additionally, we stratified data by preferred colorectal cancer screening type (i.e. FOBT, colonoscopy, etc.). Finally, articles examining medical mistrust of providers and those measuring mistrust of the healthcare system were compared to determine if differences emerged in their association with CRC screening.
Adherence to CRC screening guidelines (e.g. completed a colonoscopy/FOBT/etc. or not) was the primary outcome measure of this study. We also included studies that assessed attitudes or beliefs regarding CRC screening, such as intention to screen. We used a descriptive approach to summarize study characteristics and outcomes for all research questions. For each quantitative study, we examined the direction of association between medical mistrust and CRC screening. For qualitative studies, we identified common themes associated with medical mistrust within participant responses. Findings disaggregated by gender and level of mistrust (e.g. provider or organizational) were also highlighted in order to assess Key Questions 2 and 4. Figure 1 provides details regarding the article selection and inclusion process. The overall database search yielded 777 articles. We included an additional 19 articles relevant to our research questions from reference lists of included studies. After adjusting for duplicates, a total of 598 original articles were yielded from the initial database search, and the title and abstracts of these articles were reviewed. 476 articles were excluded during the title and abstract screening because they did not meet our inclusion criteria. We retrieved 122 full-text articles for further review and excluded another 95 articles, leaving 27 articles representing 26 unique studies for further analysis. None of the studies obtained from our manual search of reference lists from our included studies were eligible for inclusion. Of the 27 included articles, 15 were quantitative, 11 were qualitative, and one was mixed methods.
Results

Study Selection
Study Characteristics of Included Studies
Characteristics of included studies are described in Table 1 . The majority (37%) of studies were cross-sectional designs, followed by focus groups (30%). Two studies were randomized control trials. Sample sizes of the included studies ranged from 14 to 55 participants for qualitative studies, and 43 to 961 participants for quantitative studies. Articles generally focused on FOBT, colonoscopy, and sigmoidoscopy, and these screening outcomes were primarily assessed through self-reported surveys measuring past screening behavior or intention to screen. Only two articles measured CRC screening directly through methods such as chart audits or FOBT card return. While almost all articles focused on mistrust measured at the physician level (96%), 15 articles (56%) assessed both physician and organization levels of mistrust. Other outcomes addressed in studies included: knowledge of CRC risk factors, cancer fatalism, physician recommendation, and self-rated health. The majority of articles (59%) included only African American participants in the sample, and most articles (59%) sampled individuals who were 50 years of age and older. Eleven articles included participants who were younger than age 50, and one of these articles assessed CRC screening attitudes and beliefs among participants that were 18 years or older. Six articles (22%) sampled individuals who were not up to date with colorectal cancer screening or who were currently eligible for their next regular screening. Two articles (8%) sampled individuals who were first degree relatives of someone diagnosed with colorectal cancer. Table 2 summarizes the dominant themes in the qualitative studies included in this review. In nine qualitative articles, participants noted their mistrust of doctors and/ or the health care system during discussions about barriers to CRC screening. In five articles, participants expressed skepticism of provider motives for recommending colorectal cancer screening (e.g., that doctors might recommend screening unnecessarily to make money from conducting the procedure). In three articles, participants expressed mistrust of some providers' competence and training as well as the quality of care they received from the health care system. Similarly, in three articles, participants expressed worry that health care providers might treat them unfairly or give them poor quality treatment due to their race, ethnicity, gender, or socioeconomic status.
Dominant Themes from Qualitative Studies
In terms of qualitative differences by gender, themes were similar across articles for men and women. However, African American men expressed more explicit fears of medical experimentation and uneasiness about the invasiveness of colorectal cancer screening procedures, such as colonoscopies. Table 3 provides information about the trust scale properties used in the included quantitative studies. Eight different scales were used in the articles included in this review. Five of these scales measured trust in physicians/providers, one scale measured trust in the health care system, one scale measured trust in both health care providers and the health care system, and one scale measured trust in patient navigators. No specific scale was used predominantly across the articles; however, the most frequently used measure was the Group-Based Medical Mistrust Scale (n = 3). Most studies did not report measures of scale reliability or validity. However, some studies measured scale reliability and reported Cronbach's alphas. Of those studies, most reported Cronbach's alpha coefficients of above 0.80.
Psychometric Properties of Trust Scales
Two studies listed items used to measure trust that were not from a specific scale. Bynum et al. [31] used the item "How much does lack of trust in medical people interfere with your taking part in a cancer screening exam?" Gordon et al. [24] asked respondents if they would get a Mistrust of competence and quality of providers/systems Participants mistrusted some providers' competence and training as well as the quality of care they received from the health care system "Yeah like now that's my problem I don't have trust in the intern. I want the doctor, you know the young guy comes in and tells me that he didn't study this in the book yet. Let me go talk to the doctor" [43] Fyffe et al. [43] , Griffith et al. [33] , Holmes-Rovner et al. [48] Equity of health care treatment Participants worried that doctors and other health care providers may not treat them to the best of their ability due to their race, ethnicity, gender, or socioeconomic status "The men or African American-a lot of people that I know, they don't have insurance and they feel, well, they going to just brush me off and look at me and send me on home anyway, so it's no use to even going" [33] Gao et al. [44] , Griffith et al. [33] , Holmes-Rovner et al. [48] Fear of experimentation Participants expressed fear of experimentation Bastani et al. [34] , Brandzel et al. [42] , Fyffe et al. [43] , Holmes-Rovner et al. [48] Invasiveness of procedure Participants discussed sexual connotation and invasive nature of CRC screening as a barrier "It just makes you feel a little queasy, you know, somebody putting something up in there like that you understand as a man." [52] Palmer et al. [52] , Lumpkins et al. [50] , Bass et al.
[41] Table 3 Specific trust scales used in studies NS not specified colonoscopy if a trusted doctor recommended it [24] . Three studies measured trust but did not specify which measures or items were used in the study [25] [26] [27] . Table 4 illustrates detected associations between medical mistrust and CRC screening outcomes by screening type across 14 of the 15 included quantitative studies. One study was omitted because results were reported by intervention arms rather than direct associations of the medical mistrust-CRC relationship [54] . A positive association indicates studies in which higher scores of medical mistrust are associated with higher rates of CRC screening. Negative association studies show higher scores of medical mistrust associated with lower rates in CRC screening. A conditional association indicated either a positive or negative association, but only for certain subpopulations, such as gender or age group. Of the 14 studies, 18 total associations were captured, with 1 positive, 6 negative, 4 conditional and 7 studies with no association. Across included studies, 8 associations were statistically significant (p < 0.05), primarily within negative association studies (n = 5). Because included studies examined multiple associations across subgroups, the number of associations is higher than the total number of quantitative studies analyzed.
Associations Between Medical Mistrust and CRC Screening for Quantitative Studies
Of the 11 studies examining mistrust at the physician level, one positive, 4 negative, 2 conditional, and 4 no association articles were included. The majority of statistically significant associations (67%) fell in the negative association group, meaning that higher scores of medical mistrust were significantly associated with lower rates of colorectal cancer screening. Of the five studies examining mistrust at the physician and organization level, one negative, two conditional, and two no association studies were found. A single study [28] examined mistrust of patient navigators and found no significant association between medical mistrust and CRC screening.
Comparative Analysis of Findings Between Men and Women for Quantitative Studies
No studies quantitatively examined gender differences in the associations between mistrust and CRC screening. However, eight studies examined gender differences in either CRC screening adherence or medical mistrust. Results for the association between medical mistrust and CRC screening adherence among men were mixed. One study illustrated that men with low provider trust were more likely to be classified with low CRC screening latent profiles [29] . However, in comparative studies, men did not have statistically different rates of mistrust than women, and male gender role was not significantly associated with CRC screening adherence [25, 30] . Among women, results were also inconclusive. Greiner et al. [45] found that women were significantly more likely to report barriers to endoscopy screening. However, one study found that women were more likely to report colonoscopy receipt and less likely to report receiving an FOBT than men [27] . Additional studies found that women were not significantly Table 4 Associations between medical mistrust and CRC screening among African Americans for quantitative studies (n = 14)
Because many studies included multiple outcomes, the total number of associations (n = 18) exceeds the total number of included studies (n = 14) *Significant association (p < 0.05) a When higher scores of medical mistrust were associated with higher rates of CRC screening b When higher scores of medical mistrust were associated with lower rates of CRC screening c When a positive or negative association existed but only under certain conditions (e.g. differences by gender or age subgroup) more likely to participate in CRC screening than men [24, 31, 32] .
Discussion
This systematic review identified 27 studies that empirically assessed relationships between medical mistrust and CRC screening among African Americans. Overall, results linking medical mistrust to CRC screening outcomes were mixed. However, when examined by statistical significance, higher medical mistrust scores were associated with lower rates of CRC screening in our study population. This finding was notable in articles examining FOBT, colonoscopy, and sigmoidoscopy as well as in cases where physician level medical mistrust was measured. Although our quantitative results did not yield definitive linkages between medical mistrust and colorectal cancer, findings from included qualitative studies identified multiple aspects during the clinical interaction contributing to mistrust, highlighting that medical mistrust may be mitigated by positive patientprovider interactions and shared decision-making. Qualitative themes centered on aspects of patient-provider interactions that contributed to mistrust, such as skepticism of motives, perceived equity of treatment, and competence of providers. Findings from our review confirmed important deficits in the evidence base regarding colorectal cancer screening among African Americans. We found that the majority of quantitative articles linked medical mistrust to significantly lower rates of CRC screening. Furthermore, we found limited evidence evaluating organizational level mistrust and differences in CRC screening by gender. Studies examining the direct association between medical mistrust and CRC screening also indicate significant variability in measures used to capture our outcomes of interest. This finding presents emerging opportunities for future research using valid and reliable medical mistrust measures in order to fully capture the impact of mistrust in healthcare utilization and subsequent health outcomes. Emerging research is also poised to investigate more nuanced and iterative expressions of mistrust in the cancer care continuum through longitudinal or qualitative investigations. Although CRC incidence is highest among African Americans, few studies took into account CRC risk factors in recruitment and sampling strategies in this population [33, 34] . Future investigations examining CRC screening barriers among African Americans should acknowledge early incidence and severity of CRC in these populations in the recruiting and analytic framework.
Our comparative analysis of studies investigating gendered patterns of mistrust suggests that there are no distinct differences between CRC screening and mistrust associations between African American men and women. However, due to the small number of included quantitative studies (n = 8) that compared findings by gender, future studies are needed to directly examine how gender modifies the relationship between medical mistrust and CRC screening. Qualitative studies highlighted patterns of mistrust, particularly among men, that prevented CRC screening, such as fear of experimentation and invasiveness of procedure. These patterns may reflect gender role norms (e.g., beliefs about masculinity) that have scarcely been attended to in studies assessing CRC screening barriers. Several studies document associations between masculinity norms and disparate use of health services among African American men [16, 35, 36] . In one of the few studies examining psychosocial correlates of medical mistrust among African American men, Hammond determined that medical mistrust was largely influenced by masculinity norms discouraging disclosure of vulnerability [16] . Future studies investigating associations between medical mistrust and CRC screening should also include measures assessing gender norms.
This review was limited by the varied definitions and measures used to conceptualize medical mistrust among African Americans. In addition, CRC screening outcomes were largely assessed through self-reported surveys assessing attitudes and beliefs rather than rates of CRC screening completion. Due to this heterogeneity in study measures, we were unable to complete a more in-depth meta-analysis. There is also potential for publication bias due to the under-representation of null or negative findings in published research. Finally, the majority of studies utilized cross-sectional study design, thus limiting the confirmation of temporal associations between medical mistrust and subsequent CRC screening patterns. Reasons for employing a one-time, observational method of assessing screening behavior are not unusual, given the length of time between screening occurrences (i.e. generally every 5 years for sigmoidoscopy and 10 years for colonoscopy). However, future studies utilizing a sequential cohort design may mitigate issues of attrition that may arise in longitudinal research while simultaneously addressing issues of temporality that arise in cross-sectional studies.
Despite these limitations, this review highlights the importance of medical mistrust as an important construct in help-seeking for colorectal cancer screening. Emerging interest in the effects of medical mistrust and health outcomes has led to an increase in studies exploring its relationship among marginalized groups [37] [38] [39] [40] . More recently, studies exploring the role of mistrust in the African American community illustrate the importance of this construct, particularly in underutilization of preventive health services [15, 16] . This review highlights the influence of cultural attitudes and mistrust on preventive cancer services. Data synthesized in this review confirms that medical mistrust is a key construct in the CRC screening decision-making process among African Americans. Many studies included in this review rigorously examined the role of mistrust in the health care utilization process, but there is more to work to be done in determining the role of trust as African Americans move across the CRC care continuum. The paucity of available literature for this review highlights the need for additional studies to establish more conclusive linkages between medical mistrust and CRC screening patterns. Future research should continue to explore determinants of medical mistrust, both at the patient/provider and organizational level of the healthcare system. Additionally, consistent and psychometrically sound measures are needed to further build the causal relationship between mistrust and CRC screening. Findings from this review will facilitate more in-depth studies and interventions assessing trust-related barriers to CRC screening among African Americans.
